Published in Exp Mol Med on January 13, 2017
Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (2005) 29.57
Integration of biological networks and gene expression data using Cytoscape. Nat Protoc (2007) 27.10
STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res (2012) 18.26
Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology (2010) 3.03
Inflammatory mechanisms in the regulation of insulin resistance. Mol Med (2008) 2.71
Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis. Hepatology (2012) 2.62
Animal models of NASH: getting both pathology and metabolic context right. J Gastroenterol Hepatol (2008) 2.33
Development of public toxicogenomics software for microarray data management and analysis. Mutat Res (2004) 2.29
From NAFLD in clinical practice to answers from guidelines. J Hepatol (2013) 1.76
Multivariate paired data analysis: multilevel PLSDA versus OPLSDA. Metabolomics (2009) 1.58
Clinical Review: Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications. J Clin Endocrinol Metab (2013) 1.44
Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats. Dig Dis Sci (2009) 1.43
Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology (2014) 1.41
Role of toll-like receptors and their downstream molecules in the development of nonalcoholic Fatty liver disease. Gastroenterol Res Pract (2011) 1.37
Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice. Diabetologia (2007) 1.34
Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolism. Drug Metab Dispos (2010) 1.19
C-Jun NH2 terminal kinase (JNK) is an essential mediator of Toll-like receptor 2-induced corneal inflammation. J Leukoc Biol (2008) 1.11
p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice. J Hepatol (2012) 1.08
Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease. World J Gastroenterol (2014) 1.07
MassTRIX reloaded: combined analysis and visualization of transcriptome and metabolome data. PLoS One (2012) 1.06
c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver. Mol Cell Biol (2014) 1.06
Analysis of transcriptome and metabolome profiles alterations in fatty liver induced by high-fat diet in rat. Metabolism (2009) 1.00
Direct transcriptional regulation of human hepatic cytochrome P450 3A4 (CYP3A4) by peroxisome proliferator-activated receptor alpha (PPARα). Mol Pharmacol (2013) 0.99
Reduction of n-3 PUFAs, specifically DHA and EPA, and enhancement of peroxisomal beta-oxidation in type 2 diabetic rat heart. Cardiovasc Diabetol (2012) 0.88
Mechanism and clinical evidence of lipocalin-2 and adipocyte fatty acid-binding protein linking obesity and atherosclerosis. Diabetes Metab Res Rev (2014) 0.86
Characterization of four new mouse cytochrome P450 enzymes of the CYP2J subfamily. Drug Metab Dispos (2013) 0.85
Effect of valsartan on the pathological progression of hepatic fibrosis in rats with type 2 diabetes. Eur J Pharmacol (2012) 0.84
Inhibition of Glutaminyl Cyclases alleviates CCL2-mediated inflammation of non-alcoholic fatty liver disease in mice. Int J Exp Pathol (2013) 0.83
Oxidative stress is activated by free fatty acids in cultured human hepatocytes. Metab Syndr Relat Disord (2011) 0.82
Development of a microarray for two rice subspecies: characterization and validation of gene expression in rice tissues. BMC Res Notes (2014) 0.81
Retinal neuronal MCP-1 induced by AGEs stimulates TNF-α expression in rat microglia via p38, ERK, and NF-κB pathways. Mol Vis (2014) 0.80